The goal of the study is to investigate whether adding different doses of sulforaphane will
benefit the clinical symptoms and cognitive function in individuals who have schizophrenia.
This study will compare the sulforaphane with placebo. There is a thirty percent change (less
than half) of receiving the placebo. The purpose of including placebo is to judge if the
outcome is related to the study medication rather than other reasons.